Sign in

CIK 0001653087 · Accelerated filer<br>Smaller reporting company

Alector, Inc.

Sign in to watch
Ticker
ALEC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
822933343
Phone
415-231-5660
Business address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
Former names
Alector LLC
  1. 4 Grant or award Director acquired 35,000 shares (grant or award)
  2. 4 Grant or award Director acquired 35,000 shares (grant or award)
  3. 4 Grant or award Director acquired 35,000 shares (grant or award)
  4. 4 Grant or award Director acquired 35,000 shares (grant or award)
  5. 4 Open-market sale Chief Medical Officer sold 8,040 shares at $4.80 ($38,582)
  6. 4 Open-market sale President and Head of R&D sold 13,206 shares at $4.80 ($63,373)
  7. 4 Open-market sale Chief Executive Officer sold 25,135 shares at $4.80 ($120,618)
  8. 4 Open-market sale Chief Financial Officer sold 6,920 shares at $4.80 ($33,208)
  9. 4 Other disposition 10% owner disposed of 598,533 shares (other)
  10. 4 Other disposition 10% owner disposed of 598,533 shares (other)
  11. 4 Grant or award Director acquired 41,250 shares (grant or award)
  12. 4 Grant or award Director acquired 41,250 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market sale Chief Financial Officer sold 5,716 shares at $6.92 ($39,562)
  16. 4 Open-market sale Chief Executive Officer sold 18,837 shares at $6.92 ($130,386)
  17. 4 Open-market sale Chief Medical Officer sold 6,001 shares at $6.92 ($41,554)
  18. 4 Open-market sale President and Head of R&D sold 10,169 shares at $6.92 ($70,387)
  19. 4 Grant or award Director acquired 8,541 shares (grant or award)
  20. 4 Open-market sale Chief Financial Officer sold 4,574 shares at $5.56 ($25,431)

Page 5 of 16 · 301 filings